In conclusion, we validated that the expression of PD‐1 and PD‐L1 was discordant across patient‐matched primary and metastatic ccRCC tumors, with higher expression being observed in primary ccRCC tumors. This evidence concerns the gene CD274 and nonpapillary renal cell carcinoma.